Could stem cells tame Alzheimer's agitation? new pilot study seeks answers
NCT ID NCT06781333
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study is testing whether a single infusion of human mesenchymal stem cells can help control agitation, aggression, and other behavioral symptoms in people with moderate to severe Alzheimer's disease. The study involves 8 adults aged 55-90 who are already taking antipsychotic medication. The goal is to see if the stem cell treatment can reduce these difficult behaviors and possibly lower the need for antipsychotic drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGITATION IN DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Miami Department of Neurology
RECRUITINGMiami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your heart hold the key to Alzheimer's prevention?
- Could your brain help unlock Alzheimer's secrets?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a gene therapy clear the toxic tau tangle in Alzheimer's?
- Can a Voice-Based app map healthy brain aging across 80 years?